May 16, 2018 / 12:36 PM / in 7 days

BRIEF-Albireo Enrolls First Patient In Phase 3 PFIC Trial Of A4250

May 16 (Reuters) - Albireo Pharma Inc:

* ALBIREO ENROLLS FIRST PATIENT IN PHASE 3 PFIC TRIAL OF A4250 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below